[go: up one dir, main page]

MA23586A1 - TREATMENT OF NEEDS FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME - Google Patents

TREATMENT OF NEEDS FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME

Info

Publication number
MA23586A1
MA23586A1 MA23929A MA23929A MA23586A1 MA 23586 A1 MA23586 A1 MA 23586A1 MA 23929 A MA23929 A MA 23929A MA 23929 A MA23929 A MA 23929A MA 23586 A1 MA23586 A1 MA 23586A1
Authority
MA
Morocco
Prior art keywords
nicotine
smoking
needs
treatment
related syndrome
Prior art date
Application number
MA23929A
Other languages
French (fr)
Inventor
Majeti Satyanarayama
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA23586A1 publication Critical patent/MA23586A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA23929A 1994-06-23 1995-06-16 TREATMENT OF NEEDS FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME MA23586A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26466694A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
MA23586A1 true MA23586A1 (en) 1995-12-31

Family

ID=23007084

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23929A MA23586A1 (en) 1994-06-23 1995-06-16 TREATMENT OF NEEDS FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME

Country Status (6)

Country Link
AU (1) AU2702795A (en)
IL (1) IL114130A0 (en)
MA (1) MA23586A1 (en)
PE (1) PE39996A1 (en)
WO (1) WO1996000069A1 (en)
ZA (1) ZA955033B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2340397A (en) * 1996-03-21 1997-10-10 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
CA2325106A1 (en) * 1999-12-06 2001-06-06 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
CA2526432A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
ES2594867T3 (en) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
CA3090277A1 (en) 2018-02-02 2019-08-08 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (en) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg DEVICE FOR THE DEWNING OF EATING, DRINKING, SMOKING AND / OR ADDICTIVE Habits
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4959380A (en) * 1988-12-19 1990-09-25 Wilson Jordan E Method of treating people to stop smoking and composition
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
IL114130A0 (en) 1995-10-31
ZA955033B (en) 1996-02-15
PE39996A1 (en) 1996-10-03
AU2702795A (en) 1996-01-19
WO1996000069A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
MA23587A1 (en) TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
EP0925046A4 (en) TOPICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF HEMORROIDAL PAIN
FI971969A0 (en) Compositions and method of use for the treatment of hemorrhoids
FR2726191B1 (en) DEVICE FOR THE TREATMENT OF APNEA SYNDROME DURING SLEEP
DE69619433D1 (en) Tobacco smoke filters and methods of making the same
NO996314L (en) Procedure for the treatment of tobacco to reduce the content of nitrosamine and its products
DE69524365D1 (en) Process for the isolation and purification of 2'-deoxy-2 ', 2'-difluoronucleosides
PT836390E (en) CIGARETTE AND METHOD FOR THE MANUFACTURE OF CIGARETTE FOR ELECTRICAL SYSTEM OF SMOKING
DE69501493D1 (en) Removal of moisture and passivation of surfaces
NO951175D0 (en) Cigarette filter and process for its manufacture
MA23588A1 (en) TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
ATE201992T1 (en) CARBOSTYRIL DERIVATIVE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES
DE69620691D1 (en) Therapeutic agent for the treatment of hypercholesterolemia
MA23586A1 (en) TREATMENT OF NEEDS FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
DE69306328D1 (en) Device for automatic smoking of tobacco rolls and for analyzing the smoke
FR2751541B1 (en) DERMO-COSMETIC COMPOSITION CONTAINING A QUINQUINA ALKALOID AND METHOD FOR THE COSMETIC TREATMENT OF ALOPECIA
DZ3225A1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES
NO982562D0 (en) Composition for the treatment of pain
ITMI931359A1 (en) PROCEDURE AND DEVICE FOR DRYING TOBACCO
FR2751544B1 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF VULGAR WARTS
FI972055A (en) Procedure of analysis of saliva
DE69503929D1 (en) Treatment of gas mixtures
BR9507375A (en) Treatment of particulate surfaces
MD654F1 (en) Tobacco processing process Process of tobacco treatment
FR2718027B1 (en) Product intended for the treatment and prevention of alopecia.